Heron Therapeutics, Inc. /De/

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC HRTX

Report date

3/31/2026

Quarter

2026 Q1

Filed

5/13/2026

Shares

2,078

Value ($000)

2

Weight

0.0%

2019 Q4 - 2026 Q1 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q1	5/13/2026	2	0.0%	2,078	3/31/2026
2023 Q2	8/11/2023	167	0.0%	110,752	6/30/2023
2023 Q1	5/15/2023	167	0.0%	110,752	3/31/2023
2022 Q4	2/14/2023	277	0.0%	110,752	12/31/2022
2022 Q3	11/14/2022	467	0.0%	110,752	9/30/2022
2022 Q2	8/12/2022	309	0.0%	110,752	6/30/2022
2022 Q1	5/16/2022	634	0.0%	110,752	3/31/2022
2021 Q4	2/14/2022	1,014	0.0%	111,008	12/31/2021
2021 Q3	11/15/2021	1,047	0.0%	97,939	9/30/2021
2021 Q2	8/16/2021	1,604	0.0%	103,380	6/30/2021
2021 Q1	5/14/2021	1,598	0.0%	98,569	3/31/2021
2020 Q4	3/1/2021	1,998	0.0%	94,398	12/31/2020
2020 Q3	11/13/2020	1,399	0.0%	94,398	9/30/2020
2020 Q2	8/14/2020	1,326	0.0%	90,124	6/30/2020
2020 Q1	5/15/2020	1,069	0.0%	91,042	3/31/2020
2019 Q4	2/14/2020	2,142	0.0%	91,135	12/31/2019